| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 241.75B | 234.88B | 237.07B | 225.07B | 290.99B | 298.89B |
| Gross Profit | 48.62B | 39.96B | 37.34B | 28.81B | 32.33B | 36.10B |
| EBITDA | 35.06B | 39.31B | 34.64B | 28.53B | 24.66B | 24.91B |
| Net Income | 14.57B | 12.35B | 12.40B | 6.72B | 4.19B | 5.76B |
Balance Sheet | ||||||
| Total Assets | 233.31B | 227.12B | 215.90B | 211.76B | 212.35B | 192.38B |
| Cash, Cash Equivalents and Short-Term Investments | 36.86B | 33.66B | 24.21B | 26.12B | 16.82B | 18.55B |
| Total Debt | 47.65B | 33.18B | 64.52B | 77.65B | 86.46B | 88.60B |
| Total Liabilities | 100.94B | 104.00B | 103.85B | 112.87B | 124.59B | 119.59B |
| Stockholders Equity | 80.65B | 74.96B | 69.19B | 60.60B | 54.40B | 57.26B |
Cash Flow | ||||||
| Free Cash Flow | 25.99B | 19.76B | 22.45B | 20.33B | 22.99B | 26.09B |
| Operating Cash Flow | 33.95B | 27.91B | 32.81B | 27.04B | 27.75B | 28.23B |
| Investing Cash Flow | -13.31B | -12.94B | -7.63B | -11.18B | -3.42B | -744.30M |
| Financing Cash Flow | -14.63B | -8.04B | -22.93B | -14.14B | -27.04B | -18.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$228.72B | 7.66 | 19.96% | 3.32% | 1.76% | 2.25% | |
70 Outperform | HK$347.70B | 12.62 | 24.18% | 5.10% | 3.98% | 0.89% | |
62 Neutral | HK$27.11B | ― | 25.82% | 1.46% | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | HK$817.42M | 7.07 | 6.88% | ― | 15.05% | -45.24% | |
58 Neutral | HK$3.12B | 4.60 | 10.28% | 8.68% | 9.91% | -23.35% | |
42 Neutral | HK$141.53M | -2.68 | -0.58% | ― | -60.77% | -310.68% |